Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Wart protection with new cervical cancer vaccinations

  • 1 Comment

Cervical cancer vaccinations will soon be able to protect against genital warts.

From next September, the government’s nationwide vaccination programme will use Gardasil, made by Sanofi Pasteur.

Like current vaccine Cervarix, Gardasil protects against strains 16 and 18 of the human Papillomavirus (HPV) virus which cause nearly three quarters of cases of cervical cancer, but Gardasil also protects against the strains responsible for warts and lesions.

When GlaxoSmithKline’s (GSK) Ceravix was chosen in 2008, some campaigners claimed the government had made a mistake by not chosing Gardasil, with some claiming cost had played a part.

Professor David Salisbury, the government’s director of immunisation, said: “We have reflected the changes in scientific knowledge that has become available since last time.

“They are not huge changes - we still prioritise the prevention of cancer - but based on all these things, the winner is Gardasil.”

GSK did not take part in the tender process this time.

  • 1 Comment

Readers' comments (1)

  • Could NT clarify - is this decision for England, or the devolved countries too?

    Unsuitable or offensive? Report this comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.